Plazomicin

Overview

Plazomicin (ACHN 490) is a semi-synthetic aminoglycoside Antibiotic . Plazomicin acts as a substrate for Aminoglycoside acetyltransferase and Aminoglycoside phosphotransferase . Plazomicin is not modified by various common aminoglycoside-modifying enzymes . Plazomicin selectively inhibits MATE2-K . Plazomicin exhibits activity against multidrug-resistant bacteria, including carbapenem-resistant Enterobacterales.

Application

Products | Products > Disease Areas > CNS Infection | Products > Disease Areas > Escherichia Coli Infection | Products > Disease Areas > Experimental Autoimmune Encephalomyelitis | Products > Disease Areas > Experimental Autoimmune Encephalomyelitis | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-16955
• CAS No.: 1154757-24-0
• Molecular Formula: C25H48N6O10
• Molecular Weight: 592.68
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source